Adipolytic therapy is a novel technique that uses subcutaneous injections of pharmacologically active, natural detergents to chemically ablate adipose tissue. The technique has been notoriously described as mesotherapy or Lipodissolve®, and its popularity can be attributed due in large part to direct consumer advertising and controversy rather than rigorous scientific investigation. However, the following chapter describes what is perhaps best described as adipolytic therapy or lipodissolution, which is increasingly recognized in the literature as a novel method to treat fat, using injections rather than surgery or energy devices. Phosphatidyl-choline (PC), a phospholipid derived from lecithin, has been historically incorporated with its solvent, the ionic detergent sodium deoxycholate (DC), as the two primary injected medications. Recently, numerous reports attribute the fat ablation effects of this treatment to DC, which is a bile salt possessing potent cell lytic activity, and so this chapter will describe primarily the author’s experience with this compound. It is imperative to note that as of this writing, DC is not approved by any regulatory authority and therefore must be obtained from compounding pharmacies. Physicians are advised to inquire about the status of this procedure with their malpractice carrier, and become informed (and likewise appropriately consent patients) of the literature, risks, benefits, and alternatives of this technique.
Botulinum Toxin Direct Consumer Dark Skin Type Platysmal Banding Anticipate Adverse Event
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access
Duncan D, Hasengschwandtner F. Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthetic Surg J. 2005;25:530–387.CrossRefGoogle Scholar
Odo MEY, Cuce LC, Odo LM, Natrielli A. Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects. Dermatol Surg. 2007;33:178–387.CrossRefPubMedGoogle Scholar
Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg. 2003;27:315–387.CrossRefPubMedGoogle Scholar
Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol. 2005;53:973–387.CrossRefGoogle Scholar
Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2006;32:465–387.CrossRefPubMedGoogle Scholar
Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004;30:1001–387.CrossRefPubMedGoogle Scholar
Salti G, Ghersetich I, Tantussi F, Bovani B, Lotti T. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study. Dermatol Surg. 2008;34:60–387.CrossRefPubMedGoogle Scholar
Schuller-Petrovic S, Wölkart G, Neuhold N, Freisinger F, Brunner F. Tissue toxic effects of Lipostabil after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatol Surg. 2008;34:529–387.CrossRefPubMedGoogle Scholar